Scientist LIVE logo
     

Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice

Highly pathogenic avian H5N1 influenza A viruses have spread throughout Asia, Europe, and Africa, raising serious worldwide concern about their pandemic potential. Although more than 250 people have been infected with these viruses, with a consequent high rate of mortality, the molecular mechanisms responsible for the efficient transmission of H5N1 viruses among humans remain elusive.

We used a mouse model to examine the role of the amino acid at position 627 of the PB2 viral protein in efficient replication of H5N1 viruses in the mammalian respiratory tract. Viruses possessing Lys at position 627 of PB2 replicated efficiently in lungs and nasal turbinates, as well as in cells, even at the lower temperature of 33 °C. Those viruses possessing Glu at this position replicated less well in nasal turbinates than in lungs, and less well in cells at the lower temperature.

These results suggest that Lys at PB2–627 confers to avian H5N1 viruses the advantage of efficient growth in the upper and lower respiratory tracts of mammals. Therefore, efficient viral growth in the upper respiratory tract may provide a platform for the adaptation of avian H5N1 influenza viruses to humans and for efficient person-to-person virus transmission, in the context of changes in other viral properties including specificity for human (sialic acid α-2,6-galactose containing) receptors.

Authors: Masato Hatta, Yasuko Hatta, Jin Hyun Kim, Shinji Watanabe, Kyoko Shinya, Tung Nguyen, Phuong Song Lien, Quynh Mai Le, Yoshihiro Kawaoka

To read the original journal article, click here.

(This journal article was originally published in PLoS. Open Access.)


October 18, 2007

Search

Newsletter
To tell a colleague about Scientist Live, please enter their email address below

Subscribe
  Click here for
FREE subscription
to eLab, eMed and eFood
Click to subscribe magazines
 

  To view the scientistlive site map Click Here  



eFood | eLab | eMed | Subscribe | Contact us | Home
  BACK TO MAIN PAGE
EMAIL THIS ARTICLE TO A COLLEAGUE      PRIVACY STATEMENT
BACK TO TOP
Home Contact us Subscribe